Centre d'Information et de documentation du CRA Rhône-Alpes
CRA
Informations pratiques
-
Adresse
Centre d'information et de documentation
du CRA Rhône-Alpes
Centre Hospitalier le Vinatier
bât 211
95, Bd Pinel
69678 Bron CedexHoraires
Lundi au Vendredi
9h00-12h00 13h30-16h00Contact
Tél: +33(0)4 37 91 54 65
Mail
Fax: +33(0)4 37 91 54 37
-
Résultat de la recherche
2 recherche sur le mot-clé 'Positron emission tomography'
Affiner la recherche Générer le flux rss de la recherche
Partager le résultat de cette recherche Faire une suggestion
A pilot study of serotonergic modulation after long-term administration of oxytocin in autism spectrum disorder / Tetsu HIROSAWA in Autism Research, 10-5 (May 2017)
[article]
Titre : A pilot study of serotonergic modulation after long-term administration of oxytocin in autism spectrum disorder Type de document : Texte imprimé et/ou numérique Auteurs : Tetsu HIROSAWA, Auteur ; Mitsuru KIKUCHI, Auteur ; Yasuomi OUCHI, Auteur ; Tetsuya TAKAHASHI, Auteur ; Yuko YOSHIMURA, Auteur ; Hirotaka KOSAKA, Auteur ; Naoki FURUTANI, Auteur ; Hirotoshi HIRAISHI, Auteur ; Mina FUKAI, Auteur ; Masamichi YOKOKURA, Auteur ; Etsuji YOSHIKAWA, Auteur ; Tomoyasu BUNAI, Auteur ; Yoshio MINABE, Auteur Article en page(s) : p.821-828 Langues : Anglais (eng) Mots-clés : autism spectrum disorder oxytocin positron emission tomography serotonin transporter Index. décimale : PER Périodiques Résumé : Oxytocin (OT) and the serotonergic system putatively play important roles in autism spectrum disorder (ASD) etiology and symptoms, but no direct neurobiological evidence exists for long-term OT administration effects on the brain's serotonergic system. This pilot study examined 10 male participants with ASD who were administered OT intranasally for 8–10 weeks in an open-label, single-arm, nonrandomized, and uncontrolled manner. Positron emission tomography (PET) with a radiotracer (11C)?3-amino-4-(2-[(dimethylamino)methyl]phenylthio)benzonitrile (11C-DASB) was used before and after OT treatment. The binding potential of serotonin transporter (11C-DASB BPND) was then estimated. The main outcome measures were changes in 11C-DASB BPND and their correlation with changes in symptoms. ASD participants showed significantly elevated 11C-DASB BPND in the left inferior frontal gyrus extending to the left middle frontal gyrus. No significant correlation was found between the change in any clinical symptom and the change in 11C-DASB BPND. This report of a pilot study is the first describing long-term effects of OT on the brain's serotonin system in ASD. Additional randomized controlled studies must be conducted to confirm whether activation of the serotonergic system contributes to the prosocial effect of OT in people with ASD. En ligne : http://dx.doi.org/10.1002/aur.1761 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=307
in Autism Research > 10-5 (May 2017) . - p.821-828[article] A pilot study of serotonergic modulation after long-term administration of oxytocin in autism spectrum disorder [Texte imprimé et/ou numérique] / Tetsu HIROSAWA, Auteur ; Mitsuru KIKUCHI, Auteur ; Yasuomi OUCHI, Auteur ; Tetsuya TAKAHASHI, Auteur ; Yuko YOSHIMURA, Auteur ; Hirotaka KOSAKA, Auteur ; Naoki FURUTANI, Auteur ; Hirotoshi HIRAISHI, Auteur ; Mina FUKAI, Auteur ; Masamichi YOKOKURA, Auteur ; Etsuji YOSHIKAWA, Auteur ; Tomoyasu BUNAI, Auteur ; Yoshio MINABE, Auteur . - p.821-828.
Langues : Anglais (eng)
in Autism Research > 10-5 (May 2017) . - p.821-828
Mots-clés : autism spectrum disorder oxytocin positron emission tomography serotonin transporter Index. décimale : PER Périodiques Résumé : Oxytocin (OT) and the serotonergic system putatively play important roles in autism spectrum disorder (ASD) etiology and symptoms, but no direct neurobiological evidence exists for long-term OT administration effects on the brain's serotonergic system. This pilot study examined 10 male participants with ASD who were administered OT intranasally for 8–10 weeks in an open-label, single-arm, nonrandomized, and uncontrolled manner. Positron emission tomography (PET) with a radiotracer (11C)?3-amino-4-(2-[(dimethylamino)methyl]phenylthio)benzonitrile (11C-DASB) was used before and after OT treatment. The binding potential of serotonin transporter (11C-DASB BPND) was then estimated. The main outcome measures were changes in 11C-DASB BPND and their correlation with changes in symptoms. ASD participants showed significantly elevated 11C-DASB BPND in the left inferior frontal gyrus extending to the left middle frontal gyrus. No significant correlation was found between the change in any clinical symptom and the change in 11C-DASB BPND. This report of a pilot study is the first describing long-term effects of OT on the brain's serotonin system in ASD. Additional randomized controlled studies must be conducted to confirm whether activation of the serotonergic system contributes to the prosocial effect of OT in people with ASD. En ligne : http://dx.doi.org/10.1002/aur.1761 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=307 A Protocol for Sedation Free MRI and PET Imaging in Adults with Autism Spectrum Disorder / C. J. SMITH in Journal of Autism and Developmental Disorders, 49-7 (July 2019)
[article]
Titre : A Protocol for Sedation Free MRI and PET Imaging in Adults with Autism Spectrum Disorder Type de document : Texte imprimé et/ou numérique Auteurs : C. J. SMITH, Auteur ; A. BHANOT, Auteur ; E. NORMAN, Auteur ; J. E. MULLETT, Auteur ; Staci D. BILBO, Auteur ; C. J. MCDOUGLE, Auteur ; N. R. ZURCHER, Auteur ; J. M. HOOKER, Auteur Article en page(s) : p.3036-3044 Langues : Anglais (eng) Mots-clés : Autism spectrum disorder Magnetic resonance imaging Neuroimaging Positron emission tomography Training protocols Index. décimale : PER Périodiques Résumé : Imaging technologies such as positron emission tomography (PET) and magnetic resonance imaging (MRI) present unparalleled opportunities to investigate the neural basis of autism spectrum disorder (ASD). However, challenges such as deficits in social interaction, anxiety around new experiences, impaired language abilities, and hypersensitivity to sensory stimuli make participating in neuroimaging studies challenging for individuals with ASD. In this commentary, we describe the existent training protocols for preparing individuals with ASD for PET/MRI scans and our own experience developing a training protocol to facilitate the inclusion of low-functioning adults with ASD in PET-MRI studies. We hope to raise awareness of the need for more information exchange between research groups about lessons learned in this context in order to include the entire disease spectrum in neuroimaging studies. En ligne : http://dx.doi.org/10.1007/s10803-019-04010-3 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=402
in Journal of Autism and Developmental Disorders > 49-7 (July 2019) . - p.3036-3044[article] A Protocol for Sedation Free MRI and PET Imaging in Adults with Autism Spectrum Disorder [Texte imprimé et/ou numérique] / C. J. SMITH, Auteur ; A. BHANOT, Auteur ; E. NORMAN, Auteur ; J. E. MULLETT, Auteur ; Staci D. BILBO, Auteur ; C. J. MCDOUGLE, Auteur ; N. R. ZURCHER, Auteur ; J. M. HOOKER, Auteur . - p.3036-3044.
Langues : Anglais (eng)
in Journal of Autism and Developmental Disorders > 49-7 (July 2019) . - p.3036-3044
Mots-clés : Autism spectrum disorder Magnetic resonance imaging Neuroimaging Positron emission tomography Training protocols Index. décimale : PER Périodiques Résumé : Imaging technologies such as positron emission tomography (PET) and magnetic resonance imaging (MRI) present unparalleled opportunities to investigate the neural basis of autism spectrum disorder (ASD). However, challenges such as deficits in social interaction, anxiety around new experiences, impaired language abilities, and hypersensitivity to sensory stimuli make participating in neuroimaging studies challenging for individuals with ASD. In this commentary, we describe the existent training protocols for preparing individuals with ASD for PET/MRI scans and our own experience developing a training protocol to facilitate the inclusion of low-functioning adults with ASD in PET-MRI studies. We hope to raise awareness of the need for more information exchange between research groups about lessons learned in this context in order to include the entire disease spectrum in neuroimaging studies. En ligne : http://dx.doi.org/10.1007/s10803-019-04010-3 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=402